IP Library › Granted Patent US 8,915,953
Granted Patent B2
US 8,915,953 · App. 12/566,312 · Granted Dec 23, 2014

Implant made of a biodegradable magnesium alloy

Inventor: Bodo Gerold (Zellingen, DE)
Assignee: Biotronik VI Patent AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,915,953
App. No.
12/566,312
Granted
Dec 23, 2014
Kind
B2
Abstract

An implant made in total or in parts of a biodegradable magnesium alloy consisting of Y: 2.0-6.0% by weight, Nd: 1.5-4.5% by weight, Gd: 0-4.0% by weight, Dy: 0-4.0% by weight, Er: 0-4.0% by weight, Zr: 0.1-1.0% by weight, Li: 0-0.2% by weight, Al: 0-0.3% by weight, under the condition that a) a total content of Er, Gd and Dy is in the range of 0.5-4.0% by weight and b) a total content of Nd, Er, Gd and Dy is in the range of 2.0-5.5% by weight, the balance being magnesium and incidental impurities up to a total of 0.3% by weight.

Claims (40)

1. A vascular implant made in total or in parts of a biodegradable magnesium alloy consisting essentially of:

Y: from about 3.8% to about 4.0% by weight,

Nd: from about 0.04% to about 0.07% by weight,

Gd: 0 to about 2.8% by weight,

Dy: 0 to about 2.57% by weight,

Er: about 0.01% by weight,

Zr: from about 0.46% to about 0.47% by weight;

under the condition that:

a) a total content of Er, Gd and Dy is about 2.58% to about 2.81% by weight, and

b) a total content of Nd, Er, Gd and Dy is about 2.62% to about 2.88% by weight;

the balance being magnesium and incidental impurities, optionally including Al or Li, up to a total of 0.3% by weight;

wherein the area percentage of particles in the alloy having an average particle size in the range of 1 to 15 μm is less than 3%.

2. The vascular implant of claim 1 , wherein the vascular implant is a stent.

3. The vascular implant of claim 1 , wherein,

Y is 3.93% by weight,

Nd is 0.07% by weight,

Gd is 2.8% by weight,

Dy is 0% by weight,

Er is 0.01% by weight, and

Zr is 0.46% by weight.

4. The vascular implant of claim 1 , wherein

Y is 3.85% by weight,

Nd is 0.04% by weight,

Gd is 0.0% by weight,

Dy is 2.57% by weight,

Er is 0.01% by weight, and

Zr is 0.47% by weight.

5. A method of manufacturing a vascular implant, comprising:

providing a biodegradable magnesium alloy according to claim 1 , and forming the vascular implant up to a total of 0.3% by weight of the alloy.

6. The method of claim 5 , wherein the vascular implant is a stent.

7. A vascular implant made in total or in parts of a biodegradable magnesium alloy consisting essentially of:

Y is about 4.0% by weight,

Nd is about 2.3% by weight,

Gd is about 5.9% by weight,

Dy is about 0.01% by weight,

Er is about 0.02% by weight,

Zr is about 0.53% by weight; and

the balance being magnesium and incidental impurities, optionally including Al or Li, up to a total of 0.3% by weight;

wherein the area percentage of particles in the alloy having an average particle size in the range of 1 to 15 μm is less than 3%.

8. The vascular implant of claim 7 , wherein the vascular implant is a stent.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: BIOTRONIK VI PATENT AG
To: BIOTRONIK AG
Reel/Frame 045853/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2009
From: GEROLD, BODO, DR
To: BIOTRONIK VI PATENT AG
Reel/Frame 023279/0962 →
Priority Claims (1)
EP 08165463 · Sep 30, 2008 · regional
Continuity (1)
Related Publication 20100082092A1 · Apr 1, 2010